Micrornas and Exosomes: Cardiac Stem Cells in Heart Diseases Publisher Pubmed



Maleki B^{1, 2} ; Alani B³ ; Tamehri Zadeh SS⁴ ; Saadat S^{1, 2} ; Rajabi A^{2, 5} ; Ayoubzadeh SMJ^{2, 5} ; Verdi J⁶ ; Farrokhian A⁷ ; Ghanbarian H⁸ ; Noureddini M¹ ; Nejati M⁹
Source: Pathology Research and Practice Published:2022

Abstract

Treating cardiovascular diseases with cardiac stem cells (CSCs) is a valid treatment among various stem cell-based therapies. With supplying the physiological need for cardiovascular cells as their main function, under pathological circumstances, CSCs can also reproduce the myocardial cells. Although studies have identified many of CSCs’ functions, our knowledge of molecular pathways that regulate these functions is not complete enough. Either physiological or pathological studies have shown, stem cells proliferation and differentiation could be regulated by microRNAs (miRNAs). How miRNAs regulate CSC behavior is an interesting area of research that can help us study and control the function of these cells in vitro; an achievement that may be beneficial for patients with cardiovascular diseases. The secretome of stem and progenitor cells has been studied and it has been determined that exosomes are the main source of their secretion which are very small vesicles at the nanoscale and originate from endosomes, which are secreted into the extracellular space and act as key signaling organelles in intercellular communication. Mesenchymal stem cells, cardiac-derived progenitor cells, embryonic stem cells, induced pluripotent stem cells (iPSCs), and iPSC-derived cardiomyocytes release exosomes that have been shown to have cardioprotective, immunomodulatory, and reparative effects. Herein, we summarize the regulation roles of miRNAs and exosomes in cardiac stem cells. © 2021 Elsevier GmbH